ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference on May 16, 2017
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the Bank of America Merrill Lynch 2017 Healthcare Conference on Tuesday, May 16, 2017, at 10:00 a.m. Pacific Time in Las Vegas. A live webcast of ACADIA’s presentation will be accessible on the company’s website, www